Home / Services
Translational R&D strategy that de-risks the whole path.
Five service pillars and seven fields of deep expertise — engaged end-to-end, or as the one workstream that’s blocking your programme.
The five pillars.
Strategic Planning
We design the preclinical roadmap, optimize the Structure–Activity Relationship, and build the mechanistic story that survives scientific review and investor diligence. The goal is a programme that knows exactly what it must prove, and in what order.
Market Intelligence
Market research analysis and target product profile planning that point the science at a defensible commercial position. We size the opportunity, map the competitive white space, and define the profile the product must hit to win.
Audit & Risk
A translational program audit separates proven data from missing data, feeds a structured risk register, and installs explicit go/no-go decision gates. This is how capital and reputation are protected before the next big spend.
Clinical & Regulatory
Clinical readiness frameworks and evidence planning tailored to your lead markets. We translate a single innovation across FDA, EMA, ANVISA, PMDA, CDSCO and SAHPRA — where classification and evidence requirements diverge sharply.
Network & IP
IP landscape strategy and freedom-to-operate to protect the upside, plus partner identification and coordination with universities and CROs to resource the critical path. The moat and the team, built deliberately.
Where scientific depth changes the outcome.
Clementis works at the intersection of these deep-tech domains — the places where a generalist advisor cannot add value.
Advanced Nanotechnology
Green synthesis, characterization, safe-by-design, and commercialization of nanomaterials.
Precision Medicine
Mechanistic positioning and evidence strategy for targeted therapeutics.
Functional Biomaterials
Bioactive barrier and surface technologies for performance and safety.
Sustainable Materials Science
Materials engineered for scalability, circularity and regulatory durability.
Evidence-Based Nutraceuticals
Claim substantiation, formulation logic and multi-market compliance.
Translational Oncology
Cancer-focused nanomaterials and radiolabeled imaging toward the clinic.
Green Chemistry Innovation
Cleaner routes and phytochemical platforms that hold up commercially.
Adjacent deep-tech
If it sits at the nanoscience–commercial boundary, we can help you translate it.
Structured, staged, and built to hand off.
Whether it’s a single audit or a full programme, the shape is the same: understand, de-risk, decide, and equip your team to carry it forward.
1 · Scope & discover
A complimentary discovery call and, where useful, the readiness assessment define the real question and the fastest path to an answer.
2 · Audit & de-risk
We separate proven from missing data, build the risk register, and identify the gaps that must close before the next decision.
3 · Decide at a gate
Each stage ends in an explicit go/no-go recommendation — with the reasoning, risks and fallback options laid out.
4 · Equip & hand off
You keep the frameworks, dossiers and partner introductions — so momentum continues after the engagement ends.
Not sure which pillar you need?
The free assessment points to the workstream that will move your programme furthest, fastest.